| scholarly article | Q13442814 |
| P2093 | author name string | Andrew J King | |
| Douglas R Higgs | |||
| P2860 | cites work | Expression, purification, and characterization of human hemoglobins Gower-1 (zeta(2)epsilon(2)), Gower-2 (alpha(2)epsilon(2)), and Portland-2 (zeta(2)beta(2)) assembled in complex transgenic-knockout mice | Q24290747 |
| Towards elucidating the stability, dynamics and architecture of the nucleosome remodeling and deacetylase complex by using quantitative interaction proteomics | Q24301999 | ||
| A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia | Q24305920 | ||
| Cloning and characterization of mCtBP2, a co-repressor that associates with basic Krüppel-like factor and other mammalian transcriptional regulators | Q24533307 | ||
| Ontogeny of erythroid gene expression | Q24624628 | ||
| MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13 | Q24633081 | ||
| Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia | Q24652468 | ||
| Sox6 directly silences epsilon globin expression in definitive erythropoiesis | Q25257856 | ||
| Coordinated histone modifications mediated by a CtBP co-repressor complex | Q28191656 | ||
| The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities | Q28286772 | ||
| Developmental and species-divergent globin switching are driven by BCL11A | Q28506497 | ||
| BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis | Q28607483 | ||
| α-thalassaemia | Q28972372 | ||
| A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase | Q29617070 | ||
| The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis | Q30478945 | ||
| Updates of the HbVar database of human hemoglobin variants and thalassemia mutations | Q30486431 | ||
| BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations | Q30657341 | ||
| Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease | Q33628389 | ||
| Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6. | Q33788501 | ||
| An international effort to cure a global health problem: A report on the 19th Hemoglobin Switching Conference | Q33850615 | ||
| Annotation of cis-regulatory elements by identification, subclassification, and functional assessment of multispecies conserved sequences | Q33895983 | ||
| Outcomes and morbidities of patients who survive haemoglobin Bart's hydrops fetalis syndrome: 20-year retrospective review | Q88311452 | ||
| POGZ Is Required for Silencing Mouse Embryonic β-like Hemoglobin and Human Fetal Hemoglobin Expression | Q89091509 | ||
| Invasive prenatal diagnosis of α-thalassemia to control Hb Bart's hydrops fetalis syndrome: 15 years of experience | Q89283680 | ||
| KLF1 directly activates expression of the novel fetal globin repressor ZBTB7A/LRF in erythroid cells | Q89776854 | ||
| Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells | Q89893939 | ||
| Reversal of lethal alpha- and beta-thalassemias in mice by expression of human embryonic globins | Q34067764 | ||
| Generation of mice deficient in both KLF3/BKLF and KLF8 reveals a genetic interaction and a role for these factors in embryonic globin gene silencing | Q34347327 | ||
| A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. | Q34674466 | ||
| In utero hematopoietic cell transplantation for hemoglobinopathies | Q34912452 | ||
| The multifunctional role of EKLF/KLF1 during erythropoiesis | Q35797596 | ||
| Human embryonic hemopoiesis. Kinetics of progenitors and precursors underlying the yolk sac----liver transition | Q35807649 | ||
| α-Globin as a molecular target in the treatment of β-thalassemia | Q35836891 | ||
| SOX genes and neural progenitor identity | Q36049176 | ||
| Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin | Q36652029 | ||
| Role of LRF/Pokemon in lineage fate decisions | Q36761513 | ||
| Mi2β-mediated silencing of the fetal γ-globin gene in adult erythroid cells. | Q36797277 | ||
| DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease | Q36800496 | ||
| Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing | Q37102932 | ||
| Erythroid development in the mammalian embryo | Q37265915 | ||
| Genetic dissection of the α-globin super-enhancer in vivo | Q37327013 | ||
| Human embryonic zeta-globin chains in adult patients with alpha-thalassemias | Q37571538 | ||
| EKLF/KLF1, a tissue-restricted integrator of transcriptional control, chromatin remodeling, and lineage determination | Q38054642 | ||
| Transcriptional repressors: multifaceted regulators of gene expression | Q38072014 | ||
| Fetal hemoglobin Bart's hydrops fetalis: pathophysiology, prenatal diagnosis and possibility of intrauterine treatment | Q38748136 | ||
| An international registry of survivors with Hb Bart's hydrops fetalis syndrome | Q38774321 | ||
| An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. | Q39081873 | ||
| Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. | Q39908659 | ||
| The role of the polycomb complex in silencing alpha-globin gene expression in nonerythroid cells | Q39952601 | ||
| Abnormal hemoglobins with high oxygen affinity and erythrocytosis | Q41188515 | ||
| High frequencies of alpha-thalassaemia are the result of natural selection by malaria | Q41469371 | ||
| Hydrops fetalis caused by alpha-thalassemia: an emerging health care problem. | Q41727277 | ||
| Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF. | Q42370034 | ||
| A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells | Q42556241 | ||
| Haemoglobin level, proportion of haemoglobin Bart's and haemoglobin Portland in fetuses affected by homozygous α0-thalassemia from 12 to 40 weeks' gestation | Q42868760 | ||
| c-myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. | Q42946150 | ||
| KLF1 regulates BCL11A expression and γ- to β-globin gene switching | Q42950072 | ||
| Strict in vivo specificity of the Bcl11a erythroid enhancer. | Q43195768 | ||
| A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition. | Q47125490 | ||
| Mutations in Kruppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression. | Q50480667 | ||
| Mbd2-CP2c loop drives adult-type globin gene expression and definitive erythropoiesis. | Q52352789 | ||
| Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding. | Q52431252 | ||
| Integrated design, execution, and analysis of arrayed and pooled CRISPR genome-editing experiments. | Q52431517 | ||
| Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch. | Q52690497 | ||
| Alpha-thalassemia caused by a large (62 kb) deletion upstream of the human alpha globin gene cluster | Q56550741 | ||
| Survival of a hydropic infant with homozygous α-thalassemia-1 | Q61703977 | ||
| Human embryonic zeta-globin chain expression in deletional alpha-thalassemias | Q68201712 | ||
| Significant haemoglobinopathies: guidelines for screening and diagnosis | Q82476547 | ||
| P433 | issue | 1 | |
| P921 | main subject | hydrops fetalis | Q1679678 |
| P304 | page(s) | 353-360 | |
| P577 | publication date | 2018-11-01 | |
| P1433 | published in | Hematology / the Education Program of the American Society of Hematology | Q26842068 |
| P1476 | title | Potential new approaches to the management of the Hb Bart's hydrops fetalis syndrome: the most severe form of α-thalassemia | |
| P478 | volume | 2018 |
Search more.